"Synthesis of a 2-Aryl-3-Aroyl-Indole Salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent." M. B. Hadamani, M. T. MacDonough, A. Ghatak, T. E. Strecker, R. Lopez, M. Sriram, B. L. Nguyen, R. J. Kessler, A. R. Shirali, L. Liu, C. M. Garner, G. Pettit, R. E. Hamel, D. J. Chaplin, R. P. Mason, M. L. Trawick, K. G. Pinney, J. Nat. Prod., 76(9):1668-78, DOI: 10.1021/np400374w 2013.
Comparison of optical and power Doppler ultrasound imaging for non-invasive evaluation of arsenic trioxide as a vascular disrupting agent in tumors.
Alhasan M.K., Liu L., Lewis M.A., Magnusson J., Mason R.P. PLoS ONE 2012 7 9 e46106.
A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment.
Mason R.P., Zhao D., Liu L., Trawick M.L., Pinney K.G. Integr Biol (Camb) 2011 Apr 3 4 375-87.